{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T20:00:06Z","timestamp":1771012806043,"version":"3.50.1"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.juro.2012.11.003","type":"journal-article","created":{"date-parts":[[2012,11,7]],"date-time":"2012-11-07T21:45:31Z","timestamp":1352324731000},"page":"1421-1426","source":"Crossref","is-referenced-by-count":50,"title":["Prospective, Randomized, Double-Blind, Vehicle Controlled, Multicenter Phase IIb Clinical Trial of the Pore Forming Protein PRX302 for Targeted Treatment of Symptomatic Benign Prostatic Hyperplasia"],"prefix":"10.1097","volume":"189","author":[{"given":"Mostafa M.","family":"Elhilali","sequence":"first","affiliation":[{"name":"Department of Surgery, McGill University, Montreal, Quebec, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Pommerville","sequence":"additional","affiliation":[{"name":"Can-Med Clinical Research, Victoria, British Columbia, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard C.","family":"Yocum","sequence":"additional","affiliation":[{"name":"Sophiris Bio Corp., La Jolla, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosemina","family":"Merchant","sequence":"additional","affiliation":[{"name":"Sophiris Bio Corp., La Jolla, California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus G.","family":"Roehrborn","sequence":"additional","affiliation":[{"name":"Department of Urology, UT Southwestern Medical Center, Dallas, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel R.","family":"Denmeade","sequence":"additional","affiliation":[{"name":"Sidney Kimmel Comprehensive Cancer Center at the Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2012.11.003_bib1","series-title":"Urologic Diseases in America","first-page":"45","article-title":"Benign prostatic hyperplasia","author":"Wei","year":"2007"},{"key":"10.1016\/j.juro.2012.11.003_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.pcan.4500841","article-title":"Enlarged prostate: a landmark national survey of its prevalence and impact on US men and their partners","volume":"9","author":"Roehrborn","year":"2006","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.juro.2012.11.003_bib3","series-title":"Prostate Enlargement: Benign Prostatic Hyperplasia","year":"2006"},{"issue":"suppl","key":"10.1016\/j.juro.2012.11.003_bib4","first-page":"S22","article-title":"The clinical benefits of dutasteride treatment for LUTS and BPH","volume":"6","author":"Roehrborn","year":"2004","journal-title":"Rev Urol"},{"key":"10.1016\/j.juro.2012.11.003_bib5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.2165\/00002512-200522110-00002","article-title":"Combination therapy for the pharmacological management of benign prostatic hyperplasia: rationale and treatment options","volume":"22","author":"Sandhu","year":"2005","journal-title":"Drugs Aging"},{"issue":"suppl","key":"10.1016\/j.juro.2012.11.003_bib6","first-page":"S3","article-title":"The evolution of alpha-blockers for the treatment of benign prostatic hyperplasia","volume":"8","author":"Lepor","year":"2006","journal-title":"Rev Urol"},{"key":"10.1016\/j.juro.2012.11.003_bib7","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1016\/j.juro.2012.11.003_bib8","first-page":"S34","article-title":"Factors in predicting failure with medical therapy for BPH","volume":"7","author":"Kaplan","year":"2005","journal-title":"Rev Urol"},{"issue":"suppl","key":"10.1016\/j.juro.2012.11.003_bib9","first-page":"S3","article-title":"Benign prostatic hyperplasia: an overview","volume":"7","author":"Roehrborn","year":"2005","journal-title":"Rev Urol"},{"key":"10.1016\/j.juro.2012.11.003_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00240-004-0411-0","article-title":"Prostate operations: long-term effects on sexual and urinary function and quality of life","volume":"32","author":"Deliveliotis","year":"2004","journal-title":"Urol Res"},{"key":"10.1016\/j.juro.2012.11.003_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2490-6-14","article-title":"Systemic review and meta-analysis of transurethral needle ablation in symptomatic benign prostatic hyperplasia","volume":"6","author":"Bouza","year":"2006","journal-title":"BMC Urol"},{"key":"10.1016\/j.juro.2012.11.003_bib12","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s11884-007-0026-8","article-title":"Minimally invasive techniques for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: an update","volume":"2","author":"Leitao","year":"2007","journal-title":"Curr Bladder Dysfunct Rep"},{"key":"10.1016\/j.juro.2012.11.003_bib13","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1093\/jnci\/djk065","article-title":"A prostate-specific antigen-activated channel-forming toxin as therapy for prostatic disease","volume":"99","author":"Williams","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.juro.2012.11.003_bib14","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.eururo.2010.11.024","article-title":"Phase 1 and 2 studies demonstrate the safety and efficacy of intraprostatic injection of PRX302 for the targeted treatment of lower urinary tract symptoms secondary to prostatic hyperplasia","volume":"59","author":"Denmeade","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.11.003_bib15","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1016\/S0022-5347(01)66780-6","article-title":"Benign prostatic hyperplasia specific health status measures in clinical research: how much change in the American Urological Association symptom index is perceptible to patients?","volume":"154","author":"Barry","year":"1995","journal-title":"J Urol"},{"issue":"suppl","key":"10.1016\/j.juro.2012.11.003_bib16","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0022-5347(18)32010-X","article-title":"Efficacy and length of symptom improvement after botulinum toxin type A injection in BPH patients not correlated with change in prostate volume","volume":"177","author":"Chuang","year":"2007","journal-title":"J Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712054687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712054687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2012.11.003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T02:57:03Z","timestamp":1651201023000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2012.11.003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["10.1016\/j.juro.2012.11.003"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2012.11.003","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}